Severe COVID-19 Infection in Post Renal Transplant Recipients: A Single Centre Report
Singla Harshit
Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Sector -12, Chandigarh - 160012, India.
T. Samra *
Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Sector -12, Chandigarh - 160012, India.
V. Mahajan
Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Sector -12, Chandigarh - 160012, India.
D. B. Kanwar
Department of renal transplant surgery, Post Graduate Institute of Medical Education and Research, Sector -12, Chandigarh - 160012, India.
*Author to whom correspondence should be addressed.
Abstract
Kidney transplant recipients are immunocompromised and have been under the spotlight during the COVD-19 pandemic. In our ICU 27.7% of patients received remdesivir as compared to the previous study in which no remdesivir therapy was administered. We did not report any deterioration in renal function secondary to its administration but improved outcome in patients administered the same. Survival rates of patients are thus higher in our subset (53.6%), which included patients with only severe disease.
Keywords: COVID-19, post renal transplant, intensive care unit, Remdesivir